Vir Biotechnology, Inc.
VIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$521,960 | -$615,061 | $515,837 | $528,584 |
| Dep. & Amort. | $14,559 | $19,451 | $6,783 | $5,811 |
| Deferred Tax | -$2,949 | -$1,063 | -$15,186 | $15,186 |
| Stock-Based Comp. | $78,457 | $0 | $102,082 | $83,784 |
| Change in WC | -$84,007 | -$304,591 | $665,367 | -$628,394 |
| Other Non-Cash | $69,548 | $122,479 | $388,370 | -$52,560 |
| Operating Cash Flow | -$446,352 | -$778,785 | $1,663,253 | -$47,589 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7,301 | -$21,573 | -$68,006 | -$21,817 |
| Net Acquisitions | $3,372 | $100 | $0 | $140,814 |
| Inv. Purchases | -$1,235,339 | -$2,016,189 | -$1,476,965 | -$420,240 |
| Inv. Sales/Matur. | $1,738,635 | $2,202,391 | $351,510 | $301,243 |
| Other Inv. Act. | $0 | $0 | $0 | -$140,814 |
| Investing Cash Flow | $499,367 | $164,729 | -$1,193,461 | -$140,814 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$165 | -$287 | -$260 | -$259 |
| Stock Issued | $4,553 | $7,767 | $28,462 | $85,213 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$100 | $6,559 | $15,377 |
| Financing Cash Flow | $4,388 | $7,380 | $34,761 | $100,331 |
| Forex Effect | $0 | $208 | $0 | $0 |
| Net Chg. in Cash | $57,403 | -$606,468 | $504,553 | -$88,072 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $261,292 | $861,312 | $363,415 | $451,487 |
| End Cash | $318,695 | $254,844 | $867,968 | $363,415 |
| Free Cash Flow | -$453,653 | -$800,358 | $1,595,247 | -$69,406 |